Intellia Therapeutics (NTLA) Interest Coverage Ratio Growth (1y) (2016 - 2026)
Intellia Therapeutics (NTLA) Interest Coverage Ratio Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -60.44% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 787.12% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -100.36% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 53.59% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -32.04% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 73.00% |
| 10 | Intellia Therapeutics | 1.32 Bn | 1.32 Bn | - | -22.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.65% |
| Dec 31, 2025 | -880.97% |
| Sep 30, 2025 | 92.64% |
| Jun 30, 2025 | 19.96% |
| Mar 31, 2025 | 79.49% |
| Dec 31, 2024 | -5,067.76% |
| Sep 30, 2024 | -290.85% |
| Jun 30, 2024 | -355.84% |
| Mar 31, 2024 | -118.89% |
| Dec 31, 2023 | 86.48% |
| Sep 30, 2023 | -265.04% |
| Jun 30, 2023 | -107.78% |
| Mar 31, 2023 | -167.79% |
| Dec 31, 2022 | 23.91% |
| Sep 30, 2022 | -654.11% |
| Jun 30, 2022 | -1,210.23% |
| Mar 31, 2022 | -526.75% |
| Dec 31, 2021 | -12,472.88% |
| Sep 30, 2021 | 82.78% |
| Jun 30, 2021 | 89.49% |